secwatch.observer — SEC 8-K summary
======================================

Issuer:     LUDWIG ENTERPRISES, INC. (LUDG)
CIK:        0001960262
Form:       8-K
Filed at:   2024-09-17T23:59:59+00:00
Accession:  0001903596-24-000592
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ludwig Enterprises acquires mRNA Neuro Panel patent, serotonin assay IP from Nova Mentis
--------------------------------------------------------------------------------

- Acquired U.S. Patent Application 18/705375 and related IP for mRNA neuro panel and serotonin assay from Nova Mentis.
- Issued 750,000 shares of common stock to Nova Mentis, subject to one-year lock-up and quarterly sale limits.
- Company will pay a 5% royalty on commercialization: 2.5% each to Nova and Hausman until Hausman recovers $245,712 in unpaid consulting.
- IP includes data from ASD/Fragile X observational study and serotonin assays from UCF lab of Dr. Kiminobu Sugaya.
- Dr. Marvin Hausman, CSO, says IP represents over 10 years of mRNA research; intends to expand beyond breast cancer screening.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1960262/000190359624000592/0001903596-24-000592-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1960262/000190359624000592/ludg_8k.htm
  HTML page:      https://secwatch.observer/filing/0001903596-24-000592

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer